{"data":{"id":"us-ca/wic-14195.9","jurisdiction":"us-ca","citation":"WIC § 14195.9","heading":"","body":"In no case shall the director’s discretion under Section 14120 be exercised to reduce reimbursement to providers of pharmaceutical services because of increased costs in the drug component of the Medi-Cal program arising from the implementation of the open formulary concept.","path":["Welfare and Institutions Code - WIC","DIVISION 9. PUBLIC SOCIAL SERVICES [10000. - 18999.98.]","PART 3. AID AND MEDICAL ASSISTANCE [11000. - 15771.]","CHAPTER 7. Basic Health Care [14000. - 14199.97.]","ARTICLE 6.1. Medi-Cal Therapeutic Drug Utilization Review [14195. - 14196.]"],"source_url":"https://downloads.leginfo.legislature.ca.gov/pubinfo_2025.zip","current_through":"2026-09-13","vintage":"","retrieved_at":"2026-09-14T05:56:33Z","sha256":"2b5df57e441d3a4f9631cda3e8bb34a85d2e267612f24af99999643b4ddf30a5","source_id":"us-ca","stale":false,"prev":"us-ca/wic-14195.7","next":"us-ca/wic-14196"},"notice":"GroundRules: Original legal text. Not legal advice."}